Point72 Hong Kong LTD Alaunos Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $1.24 $3,348 - $10,128	-8,168 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.62 - $1.17 $5,064 - $9,556	8,168 New	8,168 $5,000
Q3 2021 Nov 15, 2021	SELL	$1.44 - $2.73 $4,468 - $8,471	-3,103 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.63 - $3.67 $8,160 - $11,388	3,103 New	3,103 $8,000
Q4 2020 Feb 16, 2021	SELL	$2.09 - $3.09 $463 - $685	-222 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.39 - $3.43 $530 - $761	222 New	222 $1,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.